Polio vaccine: is it time for a change?
作者信息
Finn A, Bell F
机构信息
Sheffield Institute for Vaccine Studies, Department of Paediatrics, University of Sheffield, Children's Hospital, UK.
出版信息
Arch Dis Child. 1998 Jun;78(6):571-3; discussion 573-4. doi: 10.1136/adc.78.6.571.
Abstract
摘要
相似文献
1
Polio vaccine: is it time for a change?脊髓灰质炎疫苗：是时候做出改变了吗？
Arch Dis Child. 1998 Jun;78(6):571-3; discussion 573-4. doi: 10.1136/adc.78.6.571.
2
Circulating vaccine derived poliovirus and the polio eradication endgame.循环疫苗衍生脊髓灰质炎病毒与脊髓灰质炎根除的最后阶段
Pan Afr Med J. 2012;12:109. Epub 2012 Aug 20.
3
Polio eradication.消灭脊髓灰质炎
Nature. 1995 Aug 24;376(6542):630. doi: 10.1038/376630e0.
4
Indian experts favour IPV to eradicate polio.印度专家赞成使用脊灰灭活疫苗来根除脊髓灰质炎。
Lancet. 2003 Oct 18;362(9392):1292. doi: 10.1016/S0140-6736(03)14623-5.
5
6
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防：采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.
7
Polio vaccine: should New Zealand make the change?脊髓灰质炎疫苗：新西兰应该做出改变吗？
N Z Med J. 1997 Sep 12;110(1051):340-2.
8
Poliomyelitis in the United States: the final chapter?美国的脊髓灰质炎：终章？
JAMA. 2004 Oct 13;292(14):1749-51. doi: 10.1001/jama.292.14.1749.
9
Vaccine policy changes and epidemiology of poliomyelitis in the United States.美国脊髓灰质炎疫苗政策变化与流行病学
JAMA. 2004 Oct 13;292(14):1696-701. doi: 10.1001/jama.292.14.1696.
10
Canada not immune to spread of polio.加拿大无法免疫脊髓灰质炎的传播。
CMAJ. 2014 Jul 8;186(10):738. doi: 10.1503/cmaj.109-4812. Epub 2014 May 26.
引用本文的文献
1
Vaccine associated paralytic poliomyelitis.疫苗相关麻痹型脊髓灰质炎
Indian J Pediatr. 2003 Jul;70(7):573-7. doi: 10.1007/BF02723161.
2
Training for NHS Direct staff needs funding.为国民保健署直接服务人员提供培训需要资金。
BMJ. 2000 Mar 25;320(7238):875.
本文引用的文献
1
Outbreaks of paralytic poliomyelitis, 1976-1995.1976 - 1995年麻痹性脊髓灰质炎疫情
J Infect Dis. 1997 Feb;175 Suppl 1:S165-72. doi: 10.1093/infdis/175.supplement_1.s165.
2
Polio eradication: surveillance implications for the United Kingdom.
J Infect Dis. 1997 Feb;175 Suppl 1:S156-9. doi: 10.1093/infdis/175.supplement_1.s156.
3
Commentary: the unfolding story of global poliomyelitis eradication.
J Infect Dis. 1997 Feb;175 Suppl 1:S1-3. doi: 10.1093/infdis/175.supplement_1.s1.
4
The future of polio immunization in the United States: are we ready for change?
Pediatr Infect Dis J. 1996 Aug;15(8):645-9. doi: 10.1097/00006454-199608000-00002.
5
Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.
Clin Infect Dis. 1996 Jan;22(1):59-62. doi: 10.1093/clinids/22.1.59.
6
7
8
Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993.1992 - 1993年荷兰脊髓灰质炎疫情期间脊髓灰质炎病毒的传播情况。
Am J Epidemiol. 1996 May 1;143(9):929-35. doi: 10.1093/oxfordjournals.aje.a008836.
9
Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated?消灭脊髓灰质炎：何时能够确定脊髓灰质炎病毒传播已被终止？
Am J Epidemiol. 1996 Apr 15;143(8):816-22. doi: 10.1093/oxfordjournals.aje.a008820.
10
Inactivated polio vaccine for the United States: a missed vaccination opportunity.
Pediatr Infect Dis J. 1995 Oct;14(10):835-9. doi: 10.1097/00006454-199510000-00003.
Zotero 插件